Literature DB >> 22681255

Seroprevalence of Babesia canis infection in clinically healthy dogs from western Romania.

Mirela Imre1, Róbert Farkas, Marius Ilie, Kálmán Imre, Ionela Hotea, Sorin Morariu, Doru Morar, Gheorghe Dărăbuş.   

Abstract

Serum samples from 197 clinically healthy dogs residing in the Banat Region, the western historical part of Romania, were assayed by an indirect fluorescent antibody test for the presence of anti-Babesia canis antibodies. Overall, the seroprevalence was 19.8% (39/197). The percent of seropositive dogs in rural areas (28.4%; 19/67) was significantly higher (P < 0.05) compared to dogs living in urban areas (15.4%; 20/130). Seroprevalence of B. canis infection in hunting dogs was also found to be significantly higher (P < 0.05) compared to canines with other lifestyles, but no significant difference was found between companion and kennel dogs. The statistical analysis showed that no significant differences (P > 0.05) were present between the seroprevalence of infected animals associated with age, gender, or breed. The hunting lifestyle was the only factor (OR = 4.57; 95% CI = 2.1-10.2; P = 0.002) positively associated with seroprevalence in dogs and can be considered the risk factor in the acquisition of infection. Also, the results of the present survey indicate that infection with B. canis in dogs is common in the sampling area and that it is an important pathogen for the local canine population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22681255     DOI: 10.1645/GE-3129.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  7 in total

1.  Infection with Babesia canis in dogs in the Algiers region: Parasitological and serological study.

Authors:  Amel Kiouani; N Azzag; S Tennah; F Ghalmi
Journal:  Vet World       Date:  2020-07-15

2.  Parasites and vector-borne pathogens in client-owned dogs in Albania. Blood pathogens and seroprevalences of parasitic and other infectious agents.

Authors:  Dietmar Hamel; Enstela Shukullari; Dhimitër Rapti; Cornelia Silaghi; Kurt Pfister; Steffen Rehbein
Journal:  Parasitol Res       Date:  2015-10-10       Impact factor: 2.289

3.  Babesia, Theileria, and Hepatozoon species in ticks infesting animal hosts in Romania.

Authors:  Martin O Andersson; Conny Tolf; Paula Tamba; Mircea Stefanache; Gabriel Radbea; Franz Rubel; Jonas Waldenström; Gerhard Dobler; Lidia Chițimia-Dobler
Journal:  Parasitol Res       Date:  2017-07-04       Impact factor: 2.289

4.  Prevention of Babesia canis in dogs: efficacy of a fixed combination of permethrin and fipronil (Effitix®) using an experimental transmission blocking model with infected Dermacentor reticulatus ticks.

Authors:  Christelle Navarro; Nadège Reymond; Josephus Fourie; Klaus Hellmann; Stéphane Bonneau
Journal:  Parasit Vectors       Date:  2015-01-17       Impact factor: 3.876

5.  Theileria annae (syn. Babesia microti-like) infection in dogs in NW Spain detected using direct and indirect diagnostic techniques: clinical report of 75 cases.

Authors:  Guadalupe Miró; Rocío Checa; Andrea Paparini; Nieves Ortega; José Luís González-Fraga; Alex Gofton; Adrián Bartolomé; Ana Montoya; Rosa Gálvez; Pedro Pablo Mayo; Peter Irwin
Journal:  Parasit Vectors       Date:  2015-04-10       Impact factor: 3.876

6.  Canine tick-borne diseases in pet dogs from Romania.

Authors:  Martin O Andersson; Conny Tolf; Paula Tamba; Mircea Stefanache; Jonas Waldenström; Gerhard Dobler; Lidia Chițimia-Dobler
Journal:  Parasit Vectors       Date:  2017-03-23       Impact factor: 3.876

7.  Molecular identification and antigenic characterization of a merozoite surface antigen and a secreted antigen of Babesia canis (BcMSA1 and BcSA1).

Authors:  Mo Zhou; Shinuo Cao; Yuzi Luo; Mingming Liu; Guanbo Wang; Paul Franck Adjou Moumouni; Charoonluk Jirapattharasate; Aiko Iguchi; Patrick Vudriko; Mohamad Alaa Terkawi; Mario Löwenstein; Angela Kern; Yoshifumi Nishikawa; Hiroshi Suzuki; Ikuo Igarashi; Xuenan Xuan
Journal:  Parasit Vectors       Date:  2016-05-03       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.